Skip to content

13F-HR filed by Vestal Point Capital, LP

Vestal Point Capital, LP filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 21:01:08 UTC, with 63 holding rows worth $3,870,755,286.

Accession
0001974915-26-000008
Filed
2026-11-16
Accepted by EDGAR
Ingested
Source
EDGAR daily index

Original filing

13F report for Q3 2026

A holdings report, 63 entries on the cover page, a total value of $3,870,755,286 stated on the cover page (in dollars after the unit check, H1), rows summing to $3,870,755,286 with VALUE read as dollars as filed, 13F file number 028-23784. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ABIVAX SA-00370M103SPONSORED ADS3,960,000$392,119,200dollars as filed
NEUROCRINE BIOSCIENCES INC64125C109COM2,500,000$354,600,000dollars as filed
BIOMARIN PHARMACEUTICAL INC09061G101COM5,525,000$331,500,000dollars as filed
ARROWHEAD PHARMACEUTICALS IN04280A100COM4,815,000$315,141,750dollars as filed
INSMED INC COM PAR $.01457669307Stock2,725,000$311,031,500dollars as filed
UNITED THERAPEUTICS CORP DEL COM91307C102Stock475,000$257,397,750dollars as filed
ASCENDIS PHARMA A/SK08588103ORD SHS *A*740,000$168,594,200dollars as filed
NURIX THERAPEUTICS INC67080M103COMMON STOCK7,025,000$166,562,750dollars as filed
TARSUS PHARMACEUTICALS INC87650L103COMMON STOCK2,033,625$159,863,261dollars as filed
ENLIVEN THERAPEUTICS INC COM29337E102Stock3,225,000$147,834,000dollars as filed
DISC MEDICINE INC COM254604101Stock1,635,000$107,027,100dollars as filed
BICARA THERAPEUTICS INC055477103COM5,525,000$102,820,250dollars as filed
DYNE THERAPEUTICS INC COM26818M108Stock6,200,000$99,882,000dollars as filed
IMMATICS N.VN44445109SHS11,200,000$98,336,000dollars as filed
TAYSHA GENE THERAPIES INC877619106COMMON STOCK18,045,000$87,879,150dollars as filed
MONTE ROSA THERAPEUTICS INC61225M102COM7,130,000$85,060,900dollars as filed
GLOBUS MED INC CL A379577208Stock915,000$68,533,500dollars as filed
CRESCENT BIOPHARMA INCG2545C104COMMON STOCK3,000,000$43,770,000dollars as filed
ZIMMER BIOMET HOLDINGS INC COM98956P102Stock475,000$42,194,250dollars as filed
TRAVERE THERAPEUTICS INC89422G107COM600,000$35,328,000dollars as filed
ARCUS BIOSCIENCES INC03969F109COM1,300,000$33,579,000dollars as filed
XENON PHARMACEUTICALS INC COM98420N105Stock850,000$31,611,500dollars as filed
NEKTAR THERAPEUTICS640268306COMMON STOCK510,000$30,877,950dollars as filed
BRIGHT MINDS BIOSCIENCES INC10919W405COMMON STOCK545,000$27,151,900dollars as filed
BRIDGEBIO PHARMA INC10806X102COM400,000$26,320,000dollars as filed
IMMUNOCORE HLDGS PLC ADS45258D105ADR850,000$25,746,500dollars as filed
INSULET CORP COM45784P101Stock175,000$22,832,250dollars as filed
TREVI THERAPEUTICS INC COM89532M101Stock1,495,000$21,408,400dollars as filed
SANOFI SA SPONSORED ADR80105N105ADR500,000$20,615,000dollars as filed
SAVARA INC805111101COM3,300,000$17,028,000dollars as filed
SPYGLASS PHARMA INC85220G109COMMON STOCK640,000$16,640,000dollars as filed
ZYMEWORKS INC98985Y108COM600,000$15,894,000dollars as filed
COGENT BIOSCIENCES INC19240Q201COM475,000$15,209,500dollars as filed
SOLID BIOSCIENCES INC83422E204COMMON STOCK2,085,000$15,074,550dollars as filed
LEXEO THERAPEUTICS INC52886X107COMMON STOCK4,320,000$14,601,600dollars as filed
AVALO THERAPEUTICS INC05338F306COMMON STOCK800,000$12,264,000dollars as filed
ZENAS BIOPHARMA INC COM98937L105Stock395,000$10,653,150dollars as filed
EVOMMUNE INC30054Y107COMMON STOCK1,250,000$10,325,000dollars as filed
VIKING THERAPEUTICS INC92686J106COM290,000$9,454,000dollars as filed
STOKE THERAPEUTICS INC86150R107COM345,000$8,970,000dollars as filed
KORSANA BIOSCIENCES INC23255M303COMMON STOCK263,105$8,419,360dollars as filed
DAMORA THERAPEUTICS INCG2646Y104COMM STK395,000$8,405,600dollars as filed
TECTONIC THERAPEUTIC INC878972108COMMON STOCK360,000$8,384,400dollars as filed
ZURA BIO LTDG9TY5A101COMMON STOCK1,860,000$7,737,600dollars as filed
GLAUKOS CORP COM377322102Stock45,000$7,388,550dollars as filed
KAILERA THERAPEUTICS INC482931102COMMON STOCK625,000$7,137,500dollars as filed
ANTERIS TECHNOLOGIES GLOBAL03675P102COMMON STOCK850,000$6,604,500dollars as filed
MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD61559X104Stock525,000$6,142,500dollars as filed
REZOLUTE INC76200L309COMMON STOCK1,455,000$6,023,700dollars as filed
FIRST TRACKS BIOTHERAPEUTICS337185102ORD SHS *A*169,738$6,015,515dollars as filed
VOYAGER THERAPEUTICS INC92915B106COMMON STOCK2,165,000$5,802,200dollars as filed
MAZE THERAPEUTICS INC COM578784100Stock175,000$4,756,500dollars as filed
OLEMA PHARMACEUTICALS INC68062P106COM420,000$3,628,800dollars as filed
PALISADE BIO INC696389402COMMON STOCK2,500,000$3,375,000dollars as filed
ENGENE THERAPEUTICS INC29286X101COM1,665,000$3,330,000dollars as filed
NEUROGENE INC64135M105COMMON STOCK115,000$3,199,300dollars as filed
IBIO INC451033708CMN2,600,000$3,068,000dollars as filed
ARRIVENT BIOPHARMA INC04272N102COM100,000$3,028,000dollars as filed
ONKURE THERAPEUTICS INC68277Q105COM CL A1,088,000$2,964,800dollars as filed
CYTOMX THERAPEUTICS INC23284F105COMMON STOCK535,000$1,455,200dollars as filed
OCULIS HOLDING AGH5870P102CMN132,000$1,232,880dollars as filed
NYXOAH S AB6S7WD106SHS479,000$661,020dollars as filed
APREA THERAPEUTICS INC03836J201COM NEW350,000$262,500dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001974915-26-000008this filing2026-11-16